This document summarizes a study that aimed to investigate the effects of JQ1, a molecule that inhibits BET proteins, on contrast-induced acute kidney injury (CI-AKI). The study used methods like immunofluorescent staining, quantitative real-time PCR, Western blot, and cell viability analysis to examine the impact of JQ1 on autophagy and inflammation pathways in kidney tissue and cells. The results showed that JQ1 protected against tubular injury and apoptosis in the kidney. By understanding how JQ1 works at a molecular level, the study provides insights into the cellular mechanisms of CI-AKI and a foundation for developing targeted therapies.